These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31332071)

  • 21. Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
    Li SA; Liu J; Xiang Y; Wang YJ; Lee WH; Zhang Y
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3144-50. PubMed ID: 24637683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the first contact management profile of cases of infectious keratitis: a hospital-based study.
    Vajpayee RB; Dada T; Saxena R; Vajpayee M; Taylor HR; Venkatesh P; Sharma N
    Cornea; 2000 Jan; 19(1):52-6. PubMed ID: 10632009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric bacterial keratitis cases in Shanghai: microbiological profile, antibiotic susceptibility and visual outcomes.
    Hong J; Chen J; Sun X; Deng SX; Chen L; Gong L; Cao W; Yu X; Xu J
    Eye (Lond); 2012 Dec; 26(12):1571-8. PubMed ID: 23079751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial Activity of Poly-epsilon-lysine Peptide Hydrogels Against Pseudomonas aeruginosa.
    Kennedy SM; Deshpande P; Gallagher AG; Horsburgh MJ; Allison HE; Kaye SB; Wellings DA; Williams RL
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):18. PubMed ID: 32776141
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Zhang H; Liu S; Yue J; Sun S; Lv Q; Jian S; Xie Y; Han L; Zhang F; Dai Y; Wang L
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Route of antibiotic administration in bacterial keratitis.
    Leibowitz HM; Ryan WJ; Kupferman A
    Arch Ophthalmol; 1981 Aug; 99(8):1420-3. PubMed ID: 6789804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
    Richards RM; Hamilton VE; Thomas MR
    J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of
    Sharma P; Elofsson M; Roy S
    Virulence; 2020 Dec; 11(1):795-804. PubMed ID: 32507000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Willcox MD
    Clin Exp Optom; 2011 Mar; 94(2):161-8. PubMed ID: 21083760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V; Sharma S; Garg P; Rao GN
    Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial keratitis after photoreactive keratectomy in a young, healthy man.
    Wee WR; Kim JY; Choi YS; Lee JH
    J Cataract Refract Surg; 1997; 23(6):954-6. PubMed ID: 9292685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Takahashi H; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):636-41. PubMed ID: 26348840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
    Moshirfar M; Mirzaian G; Feiz V; Kang PC
    J Cataract Refract Surg; 2006 Mar; 32(3):515-8. PubMed ID: 16631067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of VIP as Treatment for Bacteria-Induced Keratitis Against Multiple Pseudomonas aeruginosa Strains.
    Carion TW; McWhirter CR; Grewal DK; Berger EA
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6932-40. PubMed ID: 26513498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
    Thibodeaux BA; Dajcs JJ; Caballero AR; Marquart ME; Girgis DO; O'Callaghan RJ
    Curr Eye Res; 2004 May; 28(5):337-42. PubMed ID: 15287370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.